Drug intelligence / Profile preview

adenosine-2'-5'-diphosphate

Development stage: Unknown
Modality: Small Molecules

Overview

Adenosine-2'-5'-diphosphate is a purine ribonucleotide in which two phosphate groups are attached to the ribose moiety at the 2' and 5' positions. It is a structural analog of NADP and can be used as an affinity ligand for purification of NADP-dependent enzymes. This compound is primarily used in biochemical research rather than as a pharmaceutical agent. Its mechanism of action involves mimicking natural nucleotides, allowing it to bind nucleotide-binding proteins or enzymes, particularly those that interact with NADP or related cofactors[1][9][3]. There are no known clinical indications or approvals for therapeutic use.

Other names: Adenosine 2',5'-diphosphate2'-Adenylic acid, 5'-(dihydrogen phosphate)CAS 3805-37-6CAS3805-37-6CAS-3805-37-6

Beyond the preview

Go deeper on adenosine-2'-5'-diphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine-2'-5'-diphosphate.

Explore the full profile